Quarterly Result27 Oct 2026, 12:53 pm
Indoco Remedies Approves Q2 FY27 Unaudited Financial Results
AI Summary
Indoco Remedies Ltd announced that its Board of Directors has approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The results were reviewed by the Audit Committee and approved by the Board during a meeting held on October 27, 2026. The Statutory Auditors, M/s. Gokhale & Sathe, have issued an unmodified opinion on these financial results. The company also provided a press release and the limited review report.
Key Highlights
- Board approved unaudited financial results for Q2 FY27.
- Results are for both standalone and consolidated financials.
- Statutory Auditors issued an unmodified review opinion.
- The Board meeting concluded on October 27, 2026.
Price Impact
More from INDOCO